ISSN 1470-7330

Search site with:

Content

Current Issue

Archive

Related Journals / Articles

Information

Aims and Scope

Editors and Board

Editorial Policy

Instructions for Authors

Subscription Information

Advertising

Society

Aims

Membership

Annual Meeting

Communications

Send Email to ICIS

e-Med

Visit e-Med Web Site

Journals

Purchase

“To Promote Education in Cancer Imaging in the Multidisciplinary Management of Malignancy”

Home > Articles

The effect of tamoxifen on the genital tract Open Access Article

Abstract

Tamoxifen is a selective estrogen receptor modulator (SERM) that is widely used in the treatment of patients with breast cancer and for chemoprophylaxis in high risk women. Tamoxifen results in a spectrum of abnormalities involving the genital tract, the most significant being an increased incidence of endometrial cancer and uterine sarcoma. This article reviews the effects of tamoxifen on the genital tract and the strengths and weaknesses of various imaging modalities for evaluating the endometrium.

Author

Sandra A. Polin and Susan M. Ascher

Contact Details

Corresponding address:
Sandra A. Polin, MD, Department of Radiology, Georgetown University Hospital,
3800 Reservoir Road, Washington, DC 20007, USA

Reference

ICIS Cancer Imaging Volume 8 Issue 1
DOI: 10.1102/1470-7330.2008.0020

Date Posted

30 June 2008

Open Access Article Open Access is provided for this article.

Print PDF

Size

4.44 MB

Minimum Estimated Download Times

ADSL 2Mb/s (Broadband):	17 seconds
ADSL 512Kb/s (Broadband):	1 minute 11 seconds
64 Kb/s (ISDN):	9 minutes 28 seconds
33.3 Kb/s (Typical Modem):	18 minutes 12 seconds

No part of this publication or site may be reproduced, stored in a retrieval system, or transmitted in any form or by any means, electronic, mechanical, photocopying, recording or otherwise, without the prior written permission of the Publisher, e-MED Limited, Permissions, PO Box 66356, London, E14 1GW. Tel: +44 (0)207 719 8989 Fax: +44 (0)560 126 4446, permissions@cancerimaging.org.